Patents Examined by Samuel C. Woolwine
-
Patent number: 12043867Abstract: In some aspects, the present disclosure provides methods for identifying sequence variants, as well as methods of determining copy number of a genetic locus in a sample. Systems and kits for performing methods of the disclosure, as well as compositions produced by or useful in methods of the disclosure are also provided.Type: GrantFiled: November 12, 2021Date of Patent: July 23, 2024Assignee: ACCURAGEN HOLDINGS LIMITEDInventors: Li Weng, Malek Faham, Tobias Wittkop
-
Patent number: 12037640Abstract: Methods and kits for next-generation sequencing are disclosed. In some embodiments, the present methods comprise sequencing an insert and sequencing an insert without an intervening denaturation step. Decreased sequencing signal from insert sequences, the use of unlabeled nucleotides to form double stranded insert constructs, and the use of synthesis blocking nucleotides are also discussed.Type: GrantFiled: January 8, 2021Date of Patent: July 16, 2024Assignee: Agilent Technologies, Inc.Inventor: Kyeong Soo Jeong
-
Patent number: 12037635Abstract: A method includes coupling a molecular diagnostic test device to a power source. A biological sample is conveyed into a sample preparation module. The device is then actuated by only a single action to cause the device to perform the following functions without further user action. First, the device heats the sample via a heater of the sample preparation module to lyse a portion of the sample. Second, the device conveys the lysed sample to an amplification module and heats the sample within a reaction volume of the amplification module to amplify a nucleic acid thereby producing an output solution containing a target amplicon. The device then reacts, within a detection module, each of (i) the output solution and (ii) a reagent formulated to produce a signal that indicates a presence of the target amplicon within the output solution. A result associated with the signal is then read.Type: GrantFiled: October 22, 2021Date of Patent: July 16, 2024Assignee: Visby Medical, Inc.Inventors: Boris Andreyev, Victor Briones, Ryan T. Cena, Adam De La Zerda, Colin Kelly, Gregory Loney, Gary Schoolnik, David Swenson
-
Patent number: 12031177Abstract: Provided herein are methods of enhancing spatial resolution of an analyte using sandwich maker system. The methods and systems used herein include a first substrate that includes a plurality of probes that include poly-thymine sequence and a second substrate that includes a plurality of probes comprising a capture domain and a spatial domain.Type: GrantFiled: June 3, 2021Date of Patent: July 9, 2024Assignee: 10x Genomics, Inc.Inventors: Augusto Manuel Tentori, Hanyoup Kim, Felice Alessio Bava, Rajiv Bharadwaj
-
Patent number: 12018316Abstract: The invention provides methods of assembling a DNA molecule having a desired sequence. The methods involve contacting a DNA ligase with a plurality of short oligonucleotides to be assembled and performing the ligase chain reaction to thereby generate a set of polynucleotides. Oligonucleotides in the plurality overlap with and are complementary to a sequence of at least one other oligonucleotide in the plurality, and at least 50% of the oligonucleotides in the plurality are 6-30 nucleotides in length. The set of polynucleotides produced are contacted with a DNA polymerase and dNTPs in a mixture to join the set of polynucleotides and thereby create a DNA molecule having a desired sequence by polymerase chain assembly. The method allows for production of oligonucleotides of any length having very high sequence fidelity to a desired sequence.Type: GrantFiled: February 25, 2021Date of Patent: June 25, 2024Assignee: TELESIS BIO INC.Inventors: John E. Gill, Lixia Fu, Daniel G. Gibson
-
Patent number: 12006532Abstract: The present technology relates generally to methods and compositions for targeted nucleic acid sequence enrichment, as well as uses of such enrichment for error-corrected nucleic acid sequencing applications. In some embodiments, highly accurate, error corrected and massively parallel sequencing of nucleic acid material is possible using a combination of uniquely labeled strands in a double-stranded nucleic acid complex in such a way that each strand can be informatically related to its complementary strand, but also distinguished from it following sequencing of each strand or an amplified product derived therefrom. In various embodiments, this information can be used for the purpose of error correction of the determined sequence.Type: GrantFiled: September 16, 2022Date of Patent: June 11, 2024Assignee: UNIVERSITY OF WASHINGTONInventors: Scott R. Kennedy, Jesse J. Salk, Michael Hipp, Elizabeth Schmidt, Rosa Ana Risques, Daniela Nachmanson
-
Patent number: 11999992Abstract: Reagents for stabilizing the nucleic acids of a biological cell, compositions, kits and methods of use thereof are described. The stabilization reagents may prepare the nucleic acids within the biological cell for storage and preserve the representative population of the nucleic acids for later isolation and analysis.Type: GrantFiled: September 13, 2018Date of Patent: June 4, 2024Assignee: Bruker Cellular Analysis, Inc.Inventor: Jason M. McEwen
-
Patent number: 11987841Abstract: Embodiments of a method and/or system (e.g., for improved single molecule sequencing, etc.) can include preparing a set of unique molecular identifier (UMI)-based molecules associated with a set of target nucleic acid sequences; facilitating generation of (e.g., generating, etc.) a set of tagged nucleic acid molecules based on the set of UMI-based molecules and a set of nucleic acid molecules corresponding to (e.g., including, etc.) the set of target nucleic acid sequences; and/or facilitating (e.g., performing, etc.) single molecule sequencing with the set of tagged nucleic acid molecules.Type: GrantFiled: October 9, 2018Date of Patent: May 21, 2024Assignee: Psomagen, Inc.Inventors: Zachary Apte, Jessica Richman, Daniel Almonacid, Eduardo Morales, Luis Leon, Sara W. Bird, Juan Ugalde
-
Patent number: 11981917Abstract: Methods of modulating expression of a target nucleic acid in a cell are provided including introducing into the cell a first foreign nucleic acid encoding one or more RNAs complementary to DNA, wherein the DNA includes the target nucleic acid, introducing into the cell a second foreign nucleic acid encoding a nuclease-null Cas9 protein that binds to the DNA and is guided by the one or more RNAs, introducing into the cell a third foreign nucleic acid encoding a transcriptional regulator protein or domain, wherein the one or more RNAs, the nuclease-null Cas9 protein, and the transcriptional regulator protein or domain are expressed, wherein the one or more RNAs, the nuclease-null Cas9 protein and the transcriptional regulator protein or domain co-localize to the DNA and wherein the transcriptional regulator protein or domain regulates expression of the target nucleic acid.Type: GrantFiled: October 25, 2022Date of Patent: May 14, 2024Assignee: President and Fellows of Harvard CollegeInventors: George M. Church, Prashant G. Mali, Kevin M. Esvelt
-
Patent number: 11981956Abstract: Provided herein, in some embodiments, are compositions and methods for proximity detection of molecular targets.Type: GrantFiled: January 25, 2019Date of Patent: May 14, 2024Assignee: President and Fellows of Harvard CollegeInventors: Sinem K. Saka, Jocelyn Yoshiko Kishi, Peng Yin
-
Patent number: 11981960Abstract: Provided are methods of capturing an analyte from a biological sample using a hydrogel that includes capture probes to capture the analyte, identifying a region of interest of the biological sample, and isolating the region of interest from the biological sample by removing a portion of the hydrogel that corresponds to the region of interest. Compositions and kits for performing the methods are also provided.Type: GrantFiled: July 6, 2021Date of Patent: May 14, 2024Assignee: 10x Genomics, Inc.Inventors: Bill Kengli Lin, Jill Herschleb, Cedric Uytingco
-
Patent number: 11976306Abstract: Thermostable Cas9 nucleases. The present invention relates to the field of genetic engineering and more particularly to nucleic acid editing and genome modification. The present invention provides an isolated Cas protein or polypeptide fragment thereof having an amino acid sequence of SEQ ID NO: 1 or a sequence of at least 77% identity therewith. The Cas protein or polypeptide is capable of binding, cleaving, marking or modifying a double stranded target polynucleotide at a temperature in the range 20° C. and 100° C. inclusive. The invention further provides isolated nucleic acid molecules encoding said Cas9 nucleases, expression vectors and host cells. The invention also provides PAM sequences recognized by the Cas protein or polypeptide, The Cas9 nucleases disclosed herein provide novel tools for genetic engineering in general, in particular at elevated temperatures.Type: GrantFiled: August 16, 2017Date of Patent: May 7, 2024Assignees: Stichting Voor De Technische Wetenschappen, WAGENINGEN UNIVERSITEITInventors: John Van Der Oost, Richard Van Kranenburg, Elleke Fenna Bosma, Ioannis Mougiakos, Prarthana Mohanraju
-
Patent number: 11970692Abstract: Disclosed herein are embodiments of a fixed magnet assembly that can be implemented into automated platforms for performing polynucleotide extraction from biological samples and preparing the polynucleotides into an amplification-ready form. The fixed magnet assembly can be used to provide magnetic energy to a container containing magnetic particles and a reaction mixture of polynucleotides, in order to bring about a separation of the magnetic particles from the reaction mixture. This can prevent or reduce magnetic particle carryover in the prepared amplification-ready sample, thereby improving amplification results.Type: GrantFiled: December 10, 2020Date of Patent: April 30, 2024Assignee: Becton, Dickinson and CompanyInventors: Edward Carrese, Alexandre Daviet, Rohini Rao, Alyssa Shedlosky, Ben Hopwood, Dwight Livingston
-
Patent number: 11965217Abstract: A method and a kit for detecting Mycobacterium tuberculosis are provided. The method includes a step of performing a nested qPCR assay to a specimen. The nested qPCR assay includes a first round of amplification using external primers and a second round of amplification using internal primers and a probe. The external primers have sequences of SEQ ID NOs. 1 and 2, and the internal primers and the probe have sequences of SEQ ID NOs. 3 to 5.Type: GrantFiled: May 24, 2021Date of Patent: April 23, 2024Assignee: DELTA ELECTRONICS, INC.Inventors: Yi-Chen Li, Chih-Cheng Tsou, Min-Hsien Wu, Hsin-Yao Wang, Chien-Ru Lin
-
Patent number: 11952622Abstract: Methods for analyzing DNA-containing samples are provided. The methods can comprise isolating a single genomic equivalent of DNA from the DNA-containing sample to provide a single isolated DNA molecule. The single isolated DNA molecule can be subjected to amplification conditions in the presence of one or more sets of unique molecularly tagged primers to provide one or more amplicons. Any spurious allelic sequences generated during the amplification process are tagged with an identical molecular tag. The methods can also include a step of determining the sequence of the one or more amplicons, in which the majority sequence for each code is selected as the sequence of the single original encapsulated target. The DNA-containing sample can be a forensic sample (e.g., mixed contributor sample), a fetal genetic screening sample, or a biological cell.Type: GrantFiled: July 15, 2014Date of Patent: April 9, 2024Assignee: The Johns Hopkins UniversityInventors: Andrew B. Feldman, Jeffrey S. Lin, David Weitz, Assaf Rotem
-
Patent number: 11953495Abstract: Disclosed are a molecule detection unit, a chip and a preparation method. The molecule detection unit includes a single-hole liquid storage cavity, a liquid resistance flow channel, a buffer flow channel, a sensing electrode, a substrate, a first structural layer, a second structural layer and a sample flow channel. The first structural layer is arranged on the top of the substrate; the single-hole liquid storage cavity and the buffer flow channel are arranged in the first structural layer and are independent of each other; the liquid resistance flow channel is arranged in the first structural layer, and two ends of the liquid resistance flow channel are respectively communicated with the single-hole liquid storage cavity and the buffer flow channel; the second structural layer is arranged on the top of the first structural layer and covers the top of the buffer flow channel.Type: GrantFiled: September 20, 2023Date of Patent: April 9, 2024Assignee: Beijing Qitan Tech Co., Ltd.Inventors: Yuan Wang, Xiaoxiang Xia, Lu Song
-
Patent number: 11946099Abstract: The invention comprises a method of amplifying nucleic acids by primer extension with reduced formation of primer-primer byproducts.Type: GrantFiled: February 23, 2021Date of Patent: April 2, 2024Assignee: ROCHE SEQUENCING SOLUTIONS, INC.Inventor: Brian Godwin
-
Patent number: 11946067Abstract: The present invention concerns a genetic tool comprising at least two distinct nucleic acids optimized to facilitate the transformation and modification by homologous recombination of a bacterium of the genus Clostridium, typically a solventogenic bacterium.Type: GrantFiled: May 24, 2019Date of Patent: April 2, 2024Assignee: IFP ENERGIES NOUVELLESInventors: Nicolas Lopes Ferreira, François Wasels, Gwladys Chartier
-
Patent number: 11939604Abstract: A clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for adaptive antiviral defence (Cascade); the Cascade protein complex comprising at least CRISPR-associated protein subunits Cas7, Cas5 and Cash which includes at least one subunit with an additional amino acid sequence possessing nucleic acid or chromatin modifying, visualising, transcription activating or transcription repressing activity. The Cascade complex with additional activity is combined with an RNA molecule to produce a ribonucleoprotein complex. The RNA molecule is selected to have substantial complementarity to a target sequence. Targeted ribonucleoproteins can be used as genetic engineering tools for precise cutting of nucleic acids in homologous recombination, non-homologous end joining, gene modification, gene integration, mutation repair or for their visualisation, transcriptional activation or repression.Type: GrantFiled: February 18, 2021Date of Patent: March 26, 2024Assignee: Caribou Biosciences, Inc.Inventors: Stan Johan Jozef Brouns, John van der Oost
-
Patent number: 11920151Abstract: Provided are: a composition for DNA double-strand breaks (DSBs), comprising (1) a cytosine deaminase and an inactivated target-specific endonuclease, (2) a guide RNA, and (3) a uracil-specific excision reagent (USER); a method for producing DNA double-strand breaks by means of a cytosine deaminase using the composition; a method for analyzing a DNA nucleic acid sequence to which base editing has been introduced by means of a cytosine deaminase; and a method for identifying (or measuring or detecting) base editing, base editing efficiency at an on-target site, an off-target site, and/or target specificity by means of a cytosine deaminase.Type: GrantFiled: September 13, 2017Date of Patent: March 5, 2024Assignees: TOOLGEN INCORPORATED, SEOUL NATIONAL UNIVERSITY R&Db FOUNDATION, INSTITUTE FOR BASIC SCIENCEInventor: Daesik Kim